Gravier Pierre Insider Trading Activity

Average Profitability
25.22%
Insider Buys Quantity
1
Insider Buys Sum
$198,736.23
Insider Sells Quantity
3
Insider Sells Sum
$194,207.30

Insider Activity of Gravier Pierre

According to the SEC Form 4 filings, Gravier Pierre, being in a position of

  1. CHIEF FINANCIAL OFFICER at PTC Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 8625 shares for $652,864,
    over all time since 2023-12-12, has bought 7700 shares for $198,736, and sold 15745 shares for $971,513.

Biography of Gravier Pierre

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$652,8643100

Comparison of Insiders on Amount of Buys and Sells

2026-07-14SalePTC Therapeutics, Inc.
PTCT
CHIEF FINANCIAL OFFICER
3,494
0.0043%
$80.35$280,743-12.87%
2026-02-18SalePTC Therapeutics, Inc.
PTCT
CHIEF FINANCIAL OFFICER
2,992
0.0037%
$69.36$207,525+0.54%
2026-01-06SalePTC Therapeutics, Inc.
PTCT
CHIEF FINANCIAL OFFICER
2,139
0.0027%
$76.95$164,596-8.07%
2025-07-15SalePTC Therapeutics, Inc.
PTCT
CHIEF FINANCIAL OFFICER
2,516
0.0033%
$49.46$124,441+45.45%
2025-02-20SalePTC Therapeutics, Inc.
PTCT
CHIEF FINANCIAL OFFICER
1,167
0.0015%
$50.12$58,495+9.79%
2025-02-19SalePTC Therapeutics, Inc.
PTCT
CHIEF FINANCIAL OFFICER
1,168
0.0015%
$50.10$58,512+9.58%
2024-07-16SalePTC Therapeutics, Inc.
PTCT
CHIEF FINANCIAL OFFICER
2,269
0.0029%
$34.02$77,200+33.13%
2023-12-12PurchasePTC Therapeutics, Inc.
PTCT
CHIEF FINANCIAL OFFICER
7,700
0.0101%
$25.81$198,736+25.22%
Total: 8
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.